IL6 and keloid: IL-6 levels are observed to be increased in fibroblasts from a number of skin pathologies [28,30,42], and a genome-wide association study uncovered a single-nucleotide polymorphism in keloid patients that may lead to hyperactivated signaling in fibroblasts (originally termed the IL-6 amplifier) [43,44].